Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Menopause affects hair and skin; more research needed for treatment.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Finasteride safely reduces excessive hair growth in women.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Moderately high prolactin levels do not cause hair loss in women.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.